Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure

NCT05193045 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.

NCT NCT05193045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05193045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure
Lead sponsor
Fondation Hôpital Saint-Joseph
Phase
Observational
Overall status
Unknown status
Start date
October 28, 2021
Completion date
December 31, 2023
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

klebsiella infections